Novel ibuprofen prodrug: A possible promising agent for the management of complications of Alzheimer's disease

• Main Authors: Anjali Nayak (Author), Rashu Raju (Author), Paramita Das (Author), Kuntal Das (Author), A. Suvitha (Author), Biswa Ranjan Meher (Author), Saad Alobid (Author), Ali Ibrahim Almoteer (Author), Moneer E. Almadani (Author), Ahmed Alshehri (Author), Adel Alghamdi (Author), Fuzail Ahmad (Author), Syed Imam Rabbani (Author), Syed Mohammed Basheeruddin Asdaq (Author), Naira Nayeem (Author)
• Format: Book
• Published: Elsevier, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Alzheimer's disease (AD) is a severe, varied, and complex brain condition that gradually impairs memory and cognitive function. Epidemiological studies have shown that patients who have a history of long-term NSAID use have a decreased risk of developing AD. The objective of this st...